Krystal Biotech (KRYS) Net Cash Flow (QoQ) (2017 - 2026)
Krystal Biotech (KRYS) Net Cash Flow (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Krystal Biotech | 9.59 Bn | 8.77 Bn | 110.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -93.92% |
| Dec 31, 2025 | 166.97% |
| Sep 30, 2025 | -11.18% |
| Jun 30, 2025 | 221.33% |
| Mar 31, 2025 | -27.22% |
| Dec 31, 2024 | -202.20% |
| Sep 30, 2024 | 316.52% |
| Jun 30, 2024 | -2,723.83% |
| Mar 31, 2024 | 103.32% |
| Dec 31, 2023 | -115.17% |
| Sep 30, 2023 | -27.95% |
| Jun 30, 2023 | 739.81% |
| Mar 31, 2023 | 13.69% |
| Dec 31, 2022 | 24.27% |
| Sep 30, 2022 | 36.12% |
| Jun 30, 2022 | 29.69% |
| Mar 31, 2022 | -231.69% |
| Dec 31, 2021 | 227.31% |
| Sep 30, 2021 | 40.93% |
| Jun 30, 2021 | -154.25% |